Peramivir white powde
- Product Details
- Company Profile
1. Peramivir white powde
Peramivir white powde is an experimental anti-viral medicine to treat certain patients with severe influenza. Peramivir white powde is given by injection generally once a day for 5 days. Peramivir white powde may stop the virus from spreading inside the body and speed recovery. The standard adult dose of Peramivir white powde is 600 mg once a day, administered intravenously for 5 to 10 days. Initial treatment courses are for 5 to 10 days duration.
2. Peramivir antiviral drug
Peramivir antiviral drug is a potent, intravenously administered investigational antiviral agent that rapidly delivers high plasma concentrations to the sites of infection. Discovered by BioCryst, Peramivir antiviral drug inhibits the interactions of influenza neuraminidase, an enzyme that is critical to the spread of influenza within the host. Peramivir antiviral drug is an inhibitor of influenza A and B viruses, including strains of influenza viruses that may be resistant to available neuraminidase inhibitors. The availability of an intravenous (i.v.) neuraminidase inhibitor may be important in treating patients hospitalized with severe and potentially life-threatening influenza by ensuring that the appropriate dose is administered, which may be a concern with currently available oral or inhaled anti-influenza agents.
Verified Supplier
Shanghai Tangfang Biotechnology Co., Ltd.
- Country: China (Mainland)
- Year Established: 2010
- Business type: Manufacturers
- Integral:
Contact Details|Similar Products
Escrow ServiceMore
Secure Your Orders With escrow More Transparency,Less Uncertainty